Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.6 SEK | -3.92% | -13.66% | +26.78% |
08/05 | Transcript : Orexo AB, Q1 2024 Earnings Call, May 08, 2024 | |
17/04 | Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
OREXO AB | Specialty & Advanced Pharmaceuticals | -3.92% | -13.66% | +26.78% | +93.68% | -73.90% | 6.6Cr |
- Stock Market
- Equities
- ORX Stock
- Charts Orexo AB
- Relative Strength Chart